Verve Therapeutics
Presence
Verve Therapeutics is one of the...
Verve Therapeutics is a company listed under the stock ticker VERV (US).
Acquisition, funding and merger involving Verve Therapeutics.
- Verve Therapeutics has just announced a $60 Million fundraising (posted on June 19 2023).
Executives
View the org chart displaying its 83 main executives
Most searched biographies at Verve Therapeutics
- Sekar Kathiresan, Chief Executive Officer and Board Member
- Bo Cumbo, Director
- Sheila Mikhail, Director
Popular executive movements at Verve Therapeutics
- Frederick Fiedorek has joined the company as Chief Medical Officer (posted on September 19 2023).
Create your alert
to follow the executive moves at Verve Therapeutics.
Biotechnology
Verve Therapeutics has 2,282 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).
Popular M&A news in Biotechnology
- Endeavor BioMedicines has just announced a $132 Million fundraising (posted on April 25 2024).
- Metsera has just announced a $290 Million fundraising (posted on April 23 2024).
- Histogen has filed for bankruptcy protection (posted on April 19 2024).
Popular contacts in Biotechnology
News
Press releases by Verve Therapeutics
- News Releases | Verve Therapeutics
- Verve Therapeutics Appoints Leading Biotechnology Executive Michael MacLean to its Board of Directors – Verve Therapeutics
- Verve Therapeutics Announces Nature Publication Highlighting its Use of Base Editing to Potently and Durably Lower Blood PCSK9 and LDL-C in Non-Human Primates – Verve Therapeutics
- Verve Therapeutics to Present Preclinical Data from Gene Editing Programs for the Treatment of Atherosclerotic Cardiovascular Disease at ASGCT – Verve Therapeutics
- Verve Therapeutics Appoints Industry Leader Sheila Mikhail to its Board of Directors – Verve Therapeutics
- CRISPR 2.0: Base Editing in the Groove
- Beam, Verve stockpile cash as investors bank on gene editing progress | BioPharma Dive
- Verve selects its first CRISPR base editing treatment for human trials
- View more press releases Close
Social media about Verve Therapeutics
- Verve Therapeutics on Wikipedia, Google News & Yahoo Finance
- Verve Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Sekar Kathiresan 
Call Verve Therapeutics at +1 617...
